Tranquilizers, antidepressants, opioids and anti-psychotic medications carry special risks for older people, alone or in combination.
Dr. Donovan Maust, M.D., M.S., assistant professor of psychiatry, brought his research findings and expertise on that subject to the Michigan Psychiatric Society’s Annual Spring Frontiers in Psychiatry event Friday, April 13 at Michigan State’s Kellogg Center.
His presentation will assist fellow psychiatrists and physicians better understand:
Trends in psychotropic prescribing among older adults, both of single agents and combination use.
Understand how the risk-to-benefit calculation for psychotropic prescribing may shift as patients age.
Review evidence from policies that try to reduce specific types of psychotropic prescribing.
Frontiers in Psychiatry is jointly provided by the American Psychiatric Association and the Michigan Psychiatric Society.